These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 15836467)

  • 41. Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver.
    Dobrzyn P; Dobrzyn A; Miyazaki M; Cohen P; Asilmaz E; Hardie DG; Friedman JM; Ntambi JM
    Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6409-14. PubMed ID: 15096593
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of stearoyl-CoA desaturase-1 in skeletal muscle function and metabolism.
    Stamatikos AD; Paton CM
    Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E767-75. PubMed ID: 23941875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vitamin A regulates obesity in WNIN/Ob obese rat; independent of stearoyl-CoA desaturase-1.
    Jeyakumar SM; Vajreswari A; Giridharan NV
    Biochem Biophys Res Commun; 2008 May; 370(2):243-7. PubMed ID: 18364238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hormonal and nutritional regulation of SCD1 gene expression.
    Mauvoisin D; Mounier C
    Biochimie; 2011 Jan; 93(1):78-86. PubMed ID: 20713121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BTG1 ameliorates liver steatosis by decreasing stearoyl-CoA desaturase 1 (SCD1) abundance and altering hepatic lipid metabolism.
    Xiao F; Deng J; Guo Y; Niu Y; Yuan F; Yu J; Chen S; Guo F
    Sci Signal; 2016 May; 9(428):ra50. PubMed ID: 27188441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of potent and liver-selective stearoyl-CoA desaturase (SCD) inhibitors in an acyclic linker series.
    Lachance N; Guiral S; Huang Z; Leclerc JP; Li CS; Oballa RM; Ramtohul YK; Wang H; Wu J; Zhang L
    Bioorg Med Chem Lett; 2012 Jan; 22(1):623-7. PubMed ID: 22101133
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stearoyl-CoA desaturase-1 deficiency attenuates obesity and insulin resistance in leptin-resistant obese mice.
    Miyazaki M; Sampath H; Liu X; Flowers MT; Chu K; Dobrzyn A; Ntambi JM
    Biochem Biophys Res Commun; 2009 Mar; 380(4):818-22. PubMed ID: 19338759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism.
    Flowers MT; Ntambi JM
    Curr Opin Lipidol; 2008 Jun; 19(3):248-56. PubMed ID: 18460915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy.
    Roongta UV; Pabalan JG; Wang X; Ryseck RP; Fargnoli J; Henley BJ; Yang WP; Zhu J; Madireddi MT; Lawrence RM; Wong TW; Rupnow BA
    Mol Cancer Res; 2011 Nov; 9(11):1551-61. PubMed ID: 21954435
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent advances in stearoyl-CoA desaturase 1 inhibitors for dyslipidemia and obesity.
    Liu G
    Curr Top Med Chem; 2010; 10(4):419-33. PubMed ID: 20180759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ATF4 deficiency protects mice from high-carbohydrate-diet-induced liver steatosis.
    Li H; Meng Q; Xiao F; Chen S; Du Y; Yu J; Wang C; Guo F
    Biochem J; 2011 Sep; 438(2):283-9. PubMed ID: 21644928
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conjugated linoleic acid does not reduce body fat but decreases hepatic steatosis in adult Wistar rats.
    Purushotham A; Shrode GE; Wendel AA; Liu LF; Belury MA
    J Nutr Biochem; 2007 Oct; 18(10):676-84. PubMed ID: 17368879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beta-aminoisobutyric acid prevents diet-induced obesity in mice with partial leptin deficiency.
    Begriche K; Massart J; Abbey-Toby A; Igoudjil A; Lettéron P; Fromenty B
    Obesity (Silver Spring); 2008 Sep; 16(9):2053-67. PubMed ID: 19186330
    [TBL] [Abstract][Full Text] [Related]  

  • 55. FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth.
    Du X; Wang QR; Chan E; Merchant M; Liu J; French D; Ashkenazi A; Qing J
    Cancer Res; 2012 Nov; 72(22):5843-55. PubMed ID: 23019225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Key role of the ERK1/2 MAPK pathway in the transcriptional regulation of the Stearoyl-CoA Desaturase (SCD1) gene expression in response to leptin.
    Mauvoisin D; Prévost M; Ducheix S; Arnaud MP; Mounier C
    Mol Cell Endocrinol; 2010 May; 319(1-2):116-28. PubMed ID: 20109524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stearoyl-CoA desaturase inhibitors: update on patented compounds.
    Liu G
    Expert Opin Ther Pat; 2009 Sep; 19(9):1169-91. PubMed ID: 19691439
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and characterization of murine SCD4, a novel heart-specific stearoyl-CoA desaturase isoform regulated by leptin and dietary factors.
    Miyazaki M; Jacobson MJ; Man WC; Cohen P; Asilmaz E; Friedman JM; Ntambi JM
    J Biol Chem; 2003 Sep; 278(36):33904-11. PubMed ID: 12815040
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans.
    Stefan N; Peter A; Cegan A; Staiger H; Machann J; Schick F; Claussen CD; Fritsche A; Häring HU; Schleicher E
    Diabetologia; 2008 Apr; 51(4):648-56. PubMed ID: 18286258
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent advances on stearoyl-Coa desaturase regulation in fatty liver diseases.
    Narce M; Bellenger J; Rialland M; Bellenger S
    Curr Drug Metab; 2012 Dec; 13(10):1454-63. PubMed ID: 22978399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.